Medicare AdvantageOctober 26, 2023
Notification of specialty pharmacy medical step therapy updates
Effective for dates of service on and after December 1, 2023, updated step criteria for Iron Agents found in Clinical Criteria document CC-0182 will be implemented. The preferred product list is being expanded. Please refer to the Clinical Criteria page for more information.
Clinical UM Guidelines are publicly available on the care provider website. Visit the Clinical Criteria page to search for specific criteria.
Clinical UM Guidelines | Preferred drug(s) | Nonpreferred drug(s) |
CC-0182 | Feraheme (ferumoxytol) Ferrlecit (sodium ferric gluconate/sucrose complex) Infed (iron dextran) Venofer (iron sucrose) | Injectafer (ferric carboxymaltose) Monoferric (ferric derisomaltose) |
We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities.
Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
CABC-CR-038908-23-CPN38505
PUBLICATIONS: December 2023 Provider Newsletter
To view this article online:
Or scan this QR code with your phone